Hematologic neoplasms are cancers that start in the blood or the tissues that make blood. These are also called blood cancers. Examples include leukemia and lymphoma. These cancers can affect the bone marrow and the lymphatic system.
Every report comes from a Lived member, sent anonymously.
Have you had Chemotherapy infusion for Blood Cancers?
Blood cancers are cancers that affect how blood cells are made and how they work. Most begin in the bone marrow, the spongy tissue inside bones where stem cells develop into red blood cells (which carry oxygen), white blood cells (which fight infection) and platelets (which help blood clot). In a blood cancer, one type of developing cell grows out of control. The abnormal cells crowd out healthy ones or fail to do their normal job, which is why tiredness, frequent infections and easy bruising or bleeding are common signs. Blood cancer is an umbrella term rather than a single disease. The three main groups are leukemia, which starts in blood-forming cells and fills the marrow and blood with abnormal white cells; lymphoma, which starts in lymphocytes (infection-fighting white cells) and often collects in lymph nodes; and myeloma, which starts in plasma cells, the white cells that make antibodies. Two related groups of marrow disorders also belong to this family: myelodysplastic syndromes, where marrow cells fail to mature properly, and myeloproliferative neoplasms, where the marrow makes too many blood cells. The specific type, and whether it is fast-growing (acute) or slow-growing (chronic), shapes nearly everything about outlook and treatment.
Blood cancers arise from changes in the DNA of developing blood cells. For most people, the reason those changes happened is not known, and having a blood cancer does not mean someone did something to cause it. Risk rises with age for most types; leukemia is most common after 60, while acute lymphoblastic leukemia is the most common cancer in children. Other known risk factors depend on the type. Earlier chemotherapy or radiation treatment, smoking, and exposure to high levels of radiation or the industrial chemical benzene raise the risk of acute myeloid leukemia and myelodysplastic syndromes. A weakened immune system and certain infections raise the risk of some lymphomas. Myeloma is more common in older adults and in Black Americans, and it can run in families. A few inherited conditions also raise risk, but most people with a blood cancer have no family history of it.
A blood cancer is often first suspected from a complete blood count (CBC), a routine test that measures red cells, white cells and platelets. Counts that are unusually high or low, or abnormal-looking cells under the microscope, lead to further testing. Some slow-growing types are discovered this way in people who feel well. Confirming the diagnosis and the exact type usually requires a tissue sample. For leukemia, myeloma and the marrow disorders, this is a bone marrow aspiration and biopsy, in which a needle removes a small amount of marrow, usually from the back of the hip bone, under local anesthesia. For lymphoma, a swollen lymph node or other affected tissue is biopsied. Laboratories then examine the cells, including genetic and chromosome tests that identify the precise subtype. These findings matter because they guide which treatments are likely to work. Imaging such as CT or PET scans, and sometimes a lumbar puncture to check the fluid around the brain and spinal cord, show whether and where the disease has spread.
Treatment depends on the type of blood cancer, how fast it is growing, its genetic features, and a person's age and overall health. Care is usually led by a hematologist-oncologist, a specialist in blood cancers. Some slow-growing cancers, such as certain lymphomas, early chronic lymphocytic leukemia and myeloma that is not yet causing symptoms, do not need treatment right away. Instead they are monitored with regular checkups and blood tests, an approach called watchful waiting or active monitoring. Treatment starts if symptoms appear or test results show the disease is progressing, which spares people treatment side effects for as long as the cancer stays quiet. When treatment is needed, the main options are chemotherapy; targeted therapy, which uses drugs aimed at specific features of the cancer cells (for example, pills that block signals some leukemia and lymphoma cells depend on); immunotherapy, including antibodies that mark cancer cells for the immune system to attack; and radiation therapy for disease in particular areas. A stem cell transplant restores the marrow with healthy stem cells (a person's own or a donor's) after high-dose treatment. It can offer long-term control or cure for some people but carries significant risks and a long recovery, especially with donor cells. CAR T-cell therapy, in which a person's own immune cells are engineered in a laboratory to attack the cancer, is approved for some leukemias, lymphomas and myeloma, usually after other treatments; it can cause serious fevers, blood pressure drops and neurologic effects, so it is given at specialized centers with close monitoring. Supportive care, such as blood transfusions and medicines to prevent or treat infections, is a central part of treatment for many people. Clinical trials are an option at many stages.
Because blood cancers differ so much, there is no single course. Acute leukemias usually need intensive treatment soon after diagnosis, often including hospital stays, and the first months are demanding. Many other blood cancers behave more like long-term conditions: some people live for years with monitoring alone, and others move through periods of treatment and remission (when the cancer is controlled or undetectable). Some blood cancers can be cured, while others are managed over the long term. A specialist can explain the outlook for a specific type and subtype, since general statistics may not reflect an individual situation. During treatment, low blood counts are a frequent part of daily life. They can cause fatigue, make infections more likely and increase bruising or bleeding, so people often take extra precautions against infection and have frequent blood tests. Treatment can also affect work, finances and family routines, and support from social workers, patient organizations and counselors can help. After treatment ends, follow-up continues to watch for the cancer returning and for late effects of treatment.
See a clinician if you have ongoing tiredness, fevers or drenching night sweats, unexplained weight loss, easy bruising or bleeding, tiny red spots under the skin, frequent infections, persistent bone pain, or swollen lymph nodes in the neck, armpit or groin that do not go away. These symptoms usually have other causes, but a simple blood count can help sort them out. During treatment, call your care team right away for a fever of 100.5 F (38 C) or higher, chills, or redness and swelling where a catheter enters your body, because infections during cancer treatment can become life threatening quickly. Check with the team before taking a fever reducer, since it can hide a fever. Also call promptly about new bleeding or bruising or new shortness of breath. Call 911 for bleeding that will not stop with firm pressure, severe trouble breathing, or fainting or confusion.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Blood Cancers is like, what's helped you, or ask the community a question.